Sign in

CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company

Neumora Therapeutics, Inc.

Sign in to watch
Ticker
NMRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844367680
Phone
(857) 760-0900
Business address
260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$481,506
in 2 filings

Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Aurora Daljit Singh −$482K See Remarks sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2025-05-28 Pinto Joshua President Grant or award · Stock Option (Right to Buy) +223,034 223,034
2025-05-28 Pinto Joshua President Grant or award · Stock Option (Right to Buy) +270,828 270,828
2025-05-28 Pinto Joshua President Grant or award · Stock Option (Right to Buy) +223,034 223,034
2025-05-28 Pinto Joshua President Grant or award · Stock Option (Right to Buy) +720,084 720,084
2025-05-28 Pinto Joshua President Grant or award · Stock Option (Right to Buy) +127,448 127,448
2025-05-28 Pinto Joshua President Grant or award · Stock Option (Right to Buy) +170,000 170,000
2025-05-28 Pinto Joshua President Grant or award · Stock Option (Right to Buy) +3,000,000 3,000,000
2025-05-21 Pinto Joshua President Gift −13,202 63,750
2025-05-21 Pinto Joshua President Gift +13,202 152,167
2025-02-18 BERNS PAUL L See Remarks Sale 10b5-1 −13,871 $1.69 $23K 7,405,004
2025-02-18 Milligan Michael Lee See Remarks Sale 10b5-1 −1,978 $1.69 $3K 22,470
2025-02-18 Aurora Daljit Singh Chief Strategy Officer Sale 10b5-1 −8,565 $1.68 $14K 88,935
2025-02-18 Lenz Robert A. Head of R&D Sale 10b5-1 −5,614 $1.67 $9K 309,092
2025-02-18 Pinto Joshua President Sale 10b5-1 −8,048 $1.67 $13K 76,952
2025-02-13 Ho Maykin Director Returned to the company · Stock Option (Right to Buy) −95,586 0
2025-02-13 Ho Maykin Director Returned to the company · Stock Option (Right to Buy) −27,802 0
2025-02-13 Ho Maykin Director Returned to the company · Stock Option (Right to Buy) −28,571 0
2025-02-13 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +95,586 95,586
2025-02-13 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +27,802 27,802
2025-02-13 Ho Maykin Director Grant or award · Stock Option (Right to Buy) +28,571 28,571

Page 8 of 20 · 384 trades